Page 72 - GPD-2-4

Gene & Protein in Disease Topical Me-EGF application in melanoma tumor growth

for delivery of DNA and siRNA. Adv Drug Deliv Rev, 62(1): https://doi.org/10.1021/la403124u
12–27.
17. Andrade F, Goycoolea F, Chiappetta DA, et al., 2011,
https://doi.org/10.1016/j.addr.2009.08.004 Chitosan-grafted copolymers and chitosan-ligand
conjugates as matrices for pulmonary drug delivery. Int J
7. Kean T, Thanou M, 2010, Biodegradation, biodistribution Carbohydr Chem, 2011: 865704.
and toxicity of chitosan. Adv Drug Deliv Rev, 62(1): 3–11.
https://doi.org/10.1155/2011/865704
https://doi.org/10.1016/j.addr.2009.09.004
18. Liu GS, Liu LF, Lin CJ, et al., 2006, Gene transfer of pro-
8. Kao CC, Huang SY, Chiang CH, et al., 2021, opiomelanocortin prohormone suppressed the growth and
Microencapsulated rhEGF to facilitate epithelial healing and metastasis of melanoma: Involvement of alpha-melanocyte-
prevent scar formation of cesarean wound: A randomized stimulating hormone-mediated inhibition of the nuclear
controlled trial. Taiwan J Obstet Gynecol, 60(3): 468–473.
factor kappaB/cyclooxygenase-2 pathway. Mol Pharmacol,
https://doi.org/10.1016/j.tjog.2021.03.014 69(2): 440–451.
9. Tsai HC, Sheng C, Chang LS, et al., 2021, Chitosan- https://doi.org/10.1124/mol.105.015404
microencapsulated rhEGF in promoting wound healing. 19. Wang W, Xue C, Mao X, 2020, Chitosan: Structural
J Wound Care, 30(Sup9a): IXi–IXxi. modification, biological activity and application. Int J Biol
https://doi.org/10.12968/jowc.2021.30.Sup9a.IX Macromol, 164: 4532–4546.
10. Lin SC, Zhang X, Chen SY, et al., 2021, Microencapsulated https://doi.org/10.1016/j.ijbiomac.2020.09.042
recombinant human epidermal growth factor ameliorates 20. Kim S, Gaber MW, Zawaski JA, et al., 2009, The inhibition of
osteoarthritis in a murine model. Evid Based Complement glioma growth in vitro and in vivo by a chitosan/ellagic acid
Alternat Med, 2021: 9163279. composite biomaterial. Biomaterials, 30(27): 4743–4751.
https://doi.org/10.1155/2021/9163279 https://doi.org/10.1016/j.biomaterials.2009.05.010

11. Treskova I, Topolcan O, Windrichova J, et al., 2018, OPG, 21. Nam KS, Shon YH, 2009, Suppression of metastasis of
OPN, EGF and VEGF levels at individual breslow score human breast cancer cells by chitosan oligosaccharides.
stages in malignant melanoma. Anticancer Res, 38(8): J Microbiol Biotechnol, 19(6): 629–633.
4907–4911.
https://doi.org/10.4014/jmb.0811.603
https://doi.org/10.21873/anticanres.12806
22. Liu GS, Tsai HE, Weng WT, et al., 2011, Systemic pro-
12. Bracher A, Cardona AS, Tauber S, et al., 2013, Epidermal opiomelanocortin expression induces melanogenic
growth factor facilitates melanoma lymph node metastasis differentiation and inhibits tumor angiogenesis in established
by influencing tumor lymphangiogenesis. J Invest Dermatol, mouse melanoma. Hum Gene Ther, 22(3): 325–335.
133(1): 230–238.
https://doi.org/10.1089/hum.2010.090
https://doi.org/10.1038/jid.2012.272
23. Wu JC, Tsai HE, Hsiao YH, et al., 2020, Topical MTII
13. Shetty G, Beasley GM, Sparks S, et al., 2013, Plasma cytokine therapy suppresses melanoma through PTEN upregulation
analysis in patients with advanced extremity melanoma and cyclooxygenase II inhibition. Int J Mol Sci, 21(2): 681.
undergoing isolated limb infusion. Ann Surg Oncol, 20(4):
1128–1135. https://doi.org/10.3390/ijms21020681
https://doi.org/10.1245/s10434-012-2785-5 24. Weng CH, Wu CS, Wu JC, et al., 2020, Cisplatin-induced
giant cells formation is involved in chemoresistance of
14. Lim YJ, Jeon SR, Koh JM, et al., 2015, Tumor growth melanoma cells. Int J Mol Sci, 21(21): 7892.
suppression and enhanced radioresponse by an exogenous
epidermal growth factor in mouse xenograft models with https://doi.org/10.3390/ijms21217892
A431 cells. Cancer Res Treat, 47(4): 921–930. 25. Majumder A, Sandhu M, Banerji D, et al., 2021, The role of
https://doi.org/10.4143/crt.2014.153 HER2 and HER3 in HER2-amplified cancers beyond breast
cancers. Sci Rep, 11(1): 9091.
15. Choi J, Moon SY, Hong JP, et al., 2010, Epidermal growth
factor induces cell death in the absence of overexpressed https://doi.org/10.1038/s41598-021-88683-w
epidermal growth factor receptor and ErbB2 in various 26. Watanabe S, Yonesaka K, Tanizaki J, et al., 2019, Targeting of
human cancer cell lines. Cancer Invest, 28(5): 505–514. the HER2/HER3 signaling axis overcomes ligand-mediated
resistance to trastuzumab in HER2-positive breast cancer.
https://doi.org/10.3109/07357900902783179
Cancer Med, 8(3): 1258–1268.
16. Lee DW, Lim C, Israelachvili JN, et al., 2013, Strong adhesion
and cohesion of chitosan in aqueous solutions. Langmuir, https://doi.org/10.1002/cam4.1995
29(46): 14222–14229. 27. Krahn G, Leiter U, Kaskel P, et al., 2001, Coexpression

Volume 2 Issue 4 (2023) 8 https://doi.org/10.36922/gpd.1848